Grace Therapeutics, Inc.
GRCE
Revenue
100.00M
▲100.00M∞%
-Assets
48.47M
▲25.51M▲111.12%
12 Months ChangeLiabilities
34.51M
▲19.77M▲134.20%
12 Months ChangeFree Cash Flow
-4.21M
▲19.06M▲81.92%
3 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0001140361-24-044363
2024-10-25
Form 8-K
ID: 0001140361-24-044212
2024-10-07
Form 8-K
ID: 0001140361-24-042968
2024-09-30
Form 8-K
ID: 0001140361-24-042352
2024-09-25
Form 8-K
ID: 0001140361-24-041832
2024-08-16
Form 8-K
ID: 0000950170-24-098049
2024-08-09
Form 8-K
ID: 0000950170-24-094359
2024-08-09
Form 10-Q
ID: 0000950170-24-094348
2024-06-27
Form 8-K
ID: 0000950170-24-078447
2024-06-21
Form 8-K
ID: 0000950170-24-075880